Clinical Trial Update: Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety and efficacy of Dexlansoprazole delayed-release capsules for symptomatic non-erosive gastroesophageal reflux disease in adole…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Non-erosive Gastroesophageal Reflux Disease

Drugs mentioned

• Dexilant (dexlansoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-08-06